SHIELD THERAPEUTICS PLC ORD GBP0.015 financial statements, including revenue, expenses, profit, and loss
The total revenue of STX for the last semiannual is 9.59 M GBP, and it's 37.34% higher compared to the previous semiannual. The net income of H1 24 is -12.24 M GBP.